Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 35, 2020 - Issue 1
Related Research Data
Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells.
Source:
Taylor & Francis
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells.
Source:
Informa UK Limited
Discovery of 9H-purins as potential tubulin polymerization inhibitors: Synthesis, biological evaluation and structure-activity relationships.
Source:
Elsevier BV
1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Source:
Elsevier BV
Recent advances of cytotoxic chalconoids targeting tubulin polymerization: Synthesis and biological activity.
Source:
Elsevier BV
Microtubules as a target for anticancer drugs.
Source:
Springer Science and Business Media LLC
Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Source:
Wiley
Tubulin colchicine binding site inhibitors as vascular disrupting agents in clinical developments.
Source:
Bentham Science Publishers Ltd.
Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer
Source:
Informa Healthcare
Flavonoids: structural requirements for antiproliferative activity on breast cancer cells.
Source:
Elsevier BV
Synthesis and biological evaluation of 2',5'-dimethoxychalcone derivatives as microtubule-targeted anticancer agents
Source:
Elsevier BV
Recent developments in tubulin polymerization inhibitors: An overview
Source:
Elsevier BV
A Review on Mechanisms of Anti Tumor Activity of Chalcones
Source:
Bentham Science Publishers Ltd.
Linking provided by
